Financing round-up: Aether Biomedical, Glox Therapeutics, filu, ViaNautis Bio

UK: ViaNautis Bio, a biotech company focused on the development of genetic nanomedicines, has raised a US$25m Series A financing round. The financing was led by 4BIO alongside BGF and UCB Ventures, and with the additional participation of the Cystic Fibrosis Foundation, Eli Lilly and existing investors including Origin Capital, Meltwind and O2H. The company,…

You must be a HMI Subscriber to view this content.

Subscribe Now »